Lastly, BC cells with stably activated Oct3/4 (GFP+) evade paclitaxel-induced deaths (IC50 for MDA-MB-231) [23] to survive and proliferate significantly better than their GFP- counterparts (Figure 5A). Here, POU5F1 is linked to breast cancer.